CUTISS AG
8952 Schlieren, Grabenstrasse 11
+41 44 244 36 60
info@cutiss.swiss
After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.
CUTISS AG
Grabenstrasse 11
8952 Schlieren
10 Ergebnisse für "prognostics" unter CUTISS AG
June 2015 – CUTISS
... and Prognostics as the best business idea project. Monday evening the winners of >>venture>> 2015 have ... and Prognostics as the best business idea project. Monday evening the winners of >>venture>> 2015 have ...
15. June 2015 – CUTISS
... and Prognostics as the best business idea project. Monday evening the winners of >>venture>> 2015 have ... Prognostics as the best business idea project. Monday evening the winners of >>venture>> 2015 have been ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
1 Ergebnisse für "prognostics" unter University of Zurich
Increased expression of cellular retinol-binding protein 1 in laryn...
... its prognostics values in predicting survival. METHODS: To analyse the aberrations in the genome of ... PURPOSE: To investigate the genomic alterations in larynx carcinomas (LaCa) tissues and its prognostics ... carcinomas (LaCa) tissues and its prognostics values in predicting survival. METHODS: To analyse the ... carcinomas (LaCa) tissues and its prognostics values in predicting survival. METHODS: To analyse the ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
6 Ergebnisse für "prognostics" unter ETH Entrepreneurship
Finding Predictive Gene Groups from Microarray Data
... gene groups can be beneficial in medical diagnostics and prognostics, but they may also provide ... prognostics, but they may also provide more biological insights into gene function and regulation. Software ...
PowerPoint-Präsentation
... : two groups of variables, T and All prognostics • Set threshold for this 2 groups, for different time ... : two groups of variables, T and All prognostics • Set threshold for this 2 groups, for different time ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
1 Ergebnisse für "prognostics" unter Bio-Technopark Schlieren-Zürich
Proteomedix appoints Helge Lubenow as new CEO › BIO-TECHNOPARK® Sch...
... with utility in prostate cancer diagnostics, prognostics and therapy management. Their lead product ... company has identified novel biomarker signatures with utility in prostate cancer diagnostics, prognostics ...
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
1 Ergebnisse für "prognostics" unter Roche Glycart AG
Roche | The future is patient-centric and data-driven
... assume that modern prognostics live up to their promises, and we can predict which diseases we’re likely ... diagnostics. Let’s assume that modern prognostics live up to their promises, and we can predict which diseases ...